SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-006289
Filing Date
2024-03-01
Accepted
2024-03-01 16:09:33
Documents
17
Period of Report
2024-02-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20240228_8k.htm   iXBRL 8-K 28786
2 EXHIBIT 99.1 ex_632129.htm EX-99.1 82681
7 geovax01.jpg GRAPHIC 12553
  Complete submission text file 0001437749-24-006289.txt   289751

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20240229.xsd EX-101.SCH 3891
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20240229_def.xml EX-101.DEF 13443
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20240229_lab.xml EX-101.LAB 17670
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20240229_pre.xml EX-101.PRE 13420
18 EXTRACTED XBRL INSTANCE DOCUMENT govx20240228_8k_htm.xml XML 4782
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 24709732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)